158 related articles for article (PubMed ID: 16926360)
1. Newborn screening for metabolic disorders.
Waisbren SE
JAMA; 2006 Aug; 296(8):993-5. PubMed ID: 16926360
[No Abstract] [Full Text] [Related]
2. 221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative.
Bentler K; Zhai S; Elsbecker SA; Arnold GL; Burton BK; Vockley J; Cameron CA; Hiner SJ; Edick MJ; Berry SA;
Mol Genet Metab; 2016 Sep; 119(1-2):75-82. PubMed ID: 27477829
[TBL] [Abstract][Full Text] [Related]
3. Expanded screening of newborns for genetic disorders.
Waisbren SE; Levy HL
JAMA; 2004 Feb; 291(7):820-1; author reply 821. PubMed ID: 14970058
[No Abstract] [Full Text] [Related]
4. Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency.
van Maldegem BT; Duran M; Wanders RJ; Niezen-Koning KE; Hogeveen M; Ijlst L; Waterham HR; Wijburg FA
JAMA; 2006 Aug; 296(8):943-52. PubMed ID: 16926354
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by detecting 2-octenoyl-CoA production using high-performance liquid chromatography: a practical confirmatory test for tandem mass spectrometry newborn screening in Japan.
Tajima G; Sakura N; Yofune H; Nishimura Y; Ono H; Hasegawa Y; Hata I; Kimura M; Yamaguchi S; Shigematsu Y; Kobayashi M
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):122-30. PubMed ID: 16046200
[TBL] [Abstract][Full Text] [Related]
6. Rapid diagnosis of medium chain Acyl Co-A dehydrogenase (MCAD) deficiency in a newborn by liquid chromatography/tandem mass spectrometry.
la Marca G; Malvagia S; Donati MA; Morrone A; Pasquini E; Zammarchi E
Rapid Commun Mass Spectrom; 2003; 17(23):2688-92. PubMed ID: 14648909
[No Abstract] [Full Text] [Related]
7. [Neonatal screening for metabolic diseases: need for efficacy studies].
Williams M
Ned Tijdschr Geneeskd; 2008 Jul; 152(30):1653-6. PubMed ID: 18714517
[TBL] [Abstract][Full Text] [Related]
8. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
Bishop Hubbard H
Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
[TBL] [Abstract][Full Text] [Related]
9. Assessment of candidate variants causative of inborn metabolic diseases in SUDI cases in South Africa, and a case report.
Heathfield LJ; Bhengu W; Louw S; Martin LJ; Ramesar R
Int J Legal Med; 2020 Sep; 134(5):1639-1645. PubMed ID: 32556492
[TBL] [Abstract][Full Text] [Related]
10. Neonatal screening for inborn errors of metabolism.
Morris AA
Indian Pediatr; 2000 Dec; 37(12):1303-6. PubMed ID: 11119331
[No Abstract] [Full Text] [Related]
11. Newborn screening for inherited metabolic disease.
Grosse SD; Dezateux C
Lancet; 2007 Jan; 369(9555):5-6. PubMed ID: 17208621
[No Abstract] [Full Text] [Related]
12. Maternal medium-chain acyl-CoA dehydrogenase deficiency identified by newborn screening.
Leydiker KB; Neidich JA; Lorey F; Barr EM; Puckett RL; Lobo RM; Abdenur JE
Mol Genet Metab; 2011 May; 103(1):92-5. PubMed ID: 21354840
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome.
Dezateux C
Eur J Pediatr; 2003 Dec; 162 Suppl 1():S25-8. PubMed ID: 14628139
[TBL] [Abstract][Full Text] [Related]
14. The inborn errors of metabolism information system: A project of the Region 4 Genetics Collaborative Priority 2 Workgroup.
Berry SA; Jurek AM; Anderson C; Bentler K;
Genet Med; 2010 Dec; 12(12 Suppl):S215-9. PubMed ID: 21150367
[TBL] [Abstract][Full Text] [Related]
15. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
[TBL] [Abstract][Full Text] [Related]
16. Acyl-CoA dehydrogenase deficiency: varieties with neurological involvement.
Gordon N
Dev Med Child Neurol; 2005 Mar; 47(3):207-10. PubMed ID: 15739728
[No Abstract] [Full Text] [Related]
17. [Mass Screening for Inborn Errors of Metabolism].
Ito T
Rinsho Byori; 2015 Apr; 63(4):441-9. PubMed ID: 26536777
[TBL] [Abstract][Full Text] [Related]
18. Feature construction can improve diagnostic criteria for high-dimensional metabolic data in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
Ho S; Lukacs Z; Hoffmann GF; Lindner M; Wetter T
Clin Chem; 2007 Jul; 53(7):1330-7. PubMed ID: 17513288
[TBL] [Abstract][Full Text] [Related]
19. Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry.
Leonard JV; Dezateux C
BMJ; 2002 Jan; 324(7328):4-5. PubMed ID: 11777783
[No Abstract] [Full Text] [Related]
20. Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany).
Sander S; Janzen N; Janetzky B; Scholl S; Steuerwald U; Schäfer J; Sander J
Eur J Pediatr; 2001 May; 160(5):318-9. PubMed ID: 11388605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
